Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety study evaluating a vaccine against meningitis in infants following a birth dose of hepatitis B; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents [Phase 4]
A Phase 4 trial assessing immunogenicity and safety of Boostrix using a new syringe in adolescents aged 10 to 15 years; results completed an…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years [Phase 3]
Phase 3 trial assessing safety and immunogenicity of GSK Boostrix (Tdap) in adults 19–64; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 trial assessing immunogenicity and safety of GSK Infanrix Hexa given at 2, 4, and 6 months in healthy infants; study completed wit…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Antitetanus Vaccination for People Older Than 65 Years.
A completed clinical trial evaluated antitetanus vaccination in people older than 65 years.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine [Phase 4]
Phase 4 trial assessed immunogenicity and safety of a tetanus-diphtheria vaccine given with a 13-valent pneumococcal conjugate vaccine; the …
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]
Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results pos…
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults [Phase 3]
Phase 3 results show immunogenicity and safety of GlaxoSmithKline's Boostrix Tdap vaccine in previously boosted young adults.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride [Phase 1]
Phase 1 study assessing intra-subject variability in the bioavailability of chlorpromazine hydrochloride. The study is completed and results…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose [Phase 4]
Phase 4 trial assessing safety and immunogenicity of Adacel booster given 10 years after prior dose in adults.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children [Phase 3]
Phase 3 trial comparing REVAXIS® to DT Polio® as a second booster in 6-year-old children for diphtheria, tetanus, and poliomyelitis; study c…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE [Phase 4]
Phase 4 trial update on antibody persistence to REVAXIS or DT polio and immune response to TETRAVAC-ACELLULAIRE completed.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old [Phase 3]
Phase 3 trial assessing safety and immunogenicity of concomitant vs non-concomitant administration of REPEVAX and VAXIGRIP in adults aged 60…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older [Phase 3]
Phase 3 safety and immunogenicity update of REPEVAX followed by REVAXIS in adults 40+ years.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib [Phase 3]
Phase 3 trial shows non-inferiority of GSK's DTPw-HBV/Hib vaccine compared to two alternative formulations.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults [Phase 4]
Phase 4 trial reporting immunogenicity and safety of a booster dose of Boostrix Polio vaccine in adults previously boosted, with results pos…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses [NA]
A completed clinical trial examining how the intestinal microbiome influences immune responses to enteric and systemic vaccines, including r…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine [Phase 4]
This Phase 4 clinical trial update reports safety and immunogenicity results of a booster dose of GSK's Boostrix-Polio vaccine; results were…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety (reactogenicity) of a booster dose of GSK's DTPa-HBV-IPV/Hib vaccine, with results po…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately [Phase 3]
Phase 3 trial compares the immunogenicity and reactogenicity of the hexavalent vaccine DTPa-HBV-IPV/Hib with the separate DTPa-HBV-IPV and H…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly [Phase 2]
Phase 2 study assessing immunogenicity and safety of DTPa-HBV-IPV/Hib versus DTPa-IPV/Hib with concomitant hepatitis B administration, compl…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths [Phase 2]
Phase 2 trial evaluating immune response and safety of a DTPw-HBV/Hib booster vaccine given at 15-18 months; study completed.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age [Phase 3]
Phase 3 study evaluating immunogenicity, safety, and tolerability of a fully liquid pentavalent vaccine (DTwP-Hib-HepB) in infants aged 6-8 …
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Tdap Vaccine in Post-Partum Women [Phase 4]
A Phase 4 trial reports results for the Tdap vaccine in postpartum women, assessing protection against diphtheria, tetanus, and pertussis. T…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants [Phase 3]
Phase 3 trial comparing a DTaP-IPV-HepB-PRP-T vaccine with a DTaP-IPV-PRP-T vaccine plus Hep B in Hep B-primed infants has completed.